Liver transplant outcomes among HBV patients improved over time
Outcomes from liver transplantation due to hepatitis B infection
improved with the emergence of new therapies, though the effect was less
pronounced among women and African-Americans in a recent study.
Researchers performed a retrospective chart review to determine outcomes among 738 patients who received orthotopic liver transplantation
(OLT) due to hepatitis B infection between 1985 and 1994 (era 1), 1995
and 2004 (era 2) and 2005 and 2010 (era 3). Hepatitis B immunoglobulin
(HBIG) was the most prominent treatment method used during era 1, HBIG
with lamivudine (LAM) during era 2 and HBIG in combination with
antiviral therapy during era 3.
Labels: African-Americans, liver transplant, woman